Skip to main content

Advertisement

SpringerLink
Log in

Adiponectin Receptor Expression Predicts Favorable Prognosis in Cases of Hepatocellular Carcinoma

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Obesity influences risk, progression and prognosis of various cancers including hepatocellular carcinoma (HCC). Adipose-tissue-derived adipokines has been considered to be involved in tumorigenesis and adiponecin, one such adipokine, has antiproliferative effect on obesity-related malignancies, though variable signal pathway mediated by adiponectin receptors-AdipoR1 and AdipoR2. In this study, we investigated expression of adiponectin and adiponectin receptors in tumor and non-tumorous hepatic tissues of HCC patients and its clinicopathological significance. We collected 75 HCC tissues and 70 non-tumorous hepatic tissues from HCC patients who underwent surgical resection. The tissue microarrays were constructed and immunohistochemical study for adiponectin, AdipoR1 and AipoR2 was performed. Adiponectin and AdipoR1 expression rates were significantly lower in HCC than non-neoplastic hepatic tissues (82.7 % vs. 97.1 % and 24.0 % vs. 90 %, P = 0.005 and <0.001, respectively). Immunopositivity for adiponectin was associated with small tumor size, low Edmonson-Steiner grade and absence of other organ invasion (P = 0.015, 0.021 and 0.028, respectively). AdipoR1 expression had association with absence of vascular invasion (P = 0.028) and AdipoR2 expression was correlated with lower histologic grade and low pathologic T-stage (P = 0.003 and 0.008, respectively). Cox regression analysis revealed that low expression of AdipoR1 and AdipoR2 were associated with increased risk of recurrence and death, respectively (hazard ration = 3.222 and 14.797, respectively). These findings suggest that loss of adiponectin, and adiponectin receptors expression is associated with aggressive clinicopathological features of HCC and AdipoR1 and AdipoR2 might serve as the independent prognostic factors for HCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, Adam HO (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12:13–21

    Article  CAS  PubMed  Google Scholar 

  2. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578

    Article  PubMed  Google Scholar 

  3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638

    Article  PubMed  Google Scholar 

  4. Moller H, Mellemgaard A, Lindvig K, Olsen JH (1994) Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 30A:344–350

    Article  CAS  PubMed  Google Scholar 

  5. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439–451

    Article  CAS  PubMed  Google Scholar 

  6. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, Trichopoulos D (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89:1102–1107

    Article  CAS  PubMed  Google Scholar 

  7. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97:1688–1694

    Article  CAS  PubMed  Google Scholar 

  8. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S (2005) Prostate cancer and adiponectin. Urology 65:1168–1172

    Article  PubMed  Google Scholar 

  9. Sugiyama M, Takahashi H, Hosono K, Endo H, Kato S, Yoneda K, Nozaki Y, Fujita K, Yoneda M, Wada K, Nakagama H, Nakajima A (2009) Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol 34:339–344

    CAS  PubMed  Google Scholar 

  10. Dos Santos E, Benaitreau D, Dieudonne MN, Leneveu MC, Serazin V, Giudicelli Y, Pecquery R (2008) Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol Rep 20:971–977

    PubMed  Google Scholar 

  11. Arditi JD, Venihaki M, Karalis KP, Chrousos GP (2007) Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res 39:9–13

    Article  CAS  PubMed  Google Scholar 

  12. Bub JD, Miyazaki T, Iwamoto Y (2006) Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun 340:1158–1166

    Article  CAS  PubMed  Google Scholar 

  13. Kang JH, Lee YY, Yu BY, Yang BS, Cho KH, Yoon DK, Roh YK (2005) Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res 28:1263–1269

    Article  CAS  PubMed  Google Scholar 

  14. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345:271–279

    Article  CAS  PubMed  Google Scholar 

  15. Goldstein BJ, Scalia R (2004) Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89:2563–2568

    Article  CAS  PubMed  Google Scholar 

  16. Luo Z, Saha AK, Xiang X, Ruderman NB (2005) AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 26:69–76

    Article  CAS  PubMed  Google Scholar 

  17. Chou SH, Tseleni-Balafouta S, Moon HS, Chamberland JP, Liu X, Kavantzas N, Mantzoros CS (2010) Adiponectin receptor expression in human malignant tissues. Horm Cancer 1:136–145

    Article  CAS  PubMed  Google Scholar 

  18. Petridou ET, Mitsiades N, Gialamas S, Angelopoulos M, Skalkidou A, Dessypris N, Hsi A, Lazaris N, Polyzos A, Syrigos C, Brennan AM, Tseleni-Balafouta S, Mantzoros CS (2007) Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case–control studies. Oncology 73:261–269

    Article  CAS  PubMed  Google Scholar 

  19. Pfeiler G, Hudelist G, Wulfing P, Mattsson B, Konigsberg R, Kubista E, Singer CF (2010) Impact of AdipoR1 expression on breast cancer development. Gynecol Oncol 117:134–138

    Article  CAS  PubMed  Google Scholar 

  20. Dalamaga M, Migdalis I, Fargnoli JL, Papadavid E, Bloom E, Mitsiades N, Karmaniolas K, Pelecanos N, Tseleni-Balafouta S, Dionyssiou-Asteriou A, Mantzoros CS (2009) Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case–control study. Cancer Causes Control 20:625–633

    Article  PubMed Central  PubMed  Google Scholar 

  21. Saxena NK, Fu PP, Nagalingam A, Wang J, Handy J, Cohen C, Tighiouart M, Sharma D, Anania FA (2010) Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology 139:1762–1773, 1773 e1761-1765

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Sharma D, Wang J, Fu PP, Sharma S, Nagalingam A, Mells J, Handy J, Page AJ, Cohen C, Anania FA, Saxena NK (2010) Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology 52:1713–1722

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Shen C, Zhao CY, Zhang R, Qiao L (2012) Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity. Front Biosci 17:2356–2370

    Article  Google Scholar 

  24. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM (2004) Obesity and hepatocellular carcinoma. Gastroenterology 127:S97–S103

    Article  CAS  PubMed  Google Scholar 

  25. Yu MW, Shih WL, Lin CL, Liu CJ, Jian JW, Tsai KS, Chen CJ (2008) Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol 26:5576–5582

    Article  PubMed  Google Scholar 

  26. Lai MS, Hsieh MS, Chiu YH, Chen TH (2006) Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology 43:1295–1302

    Article  PubMed  Google Scholar 

  27. Otani K, Kitayama J, Kamei T, Soma D, Miyato H, Yamauchi T, Kadowaki T, Nagawa H (2010) Adiponectin receptors are downregulated in human gastric cancer. J Gastroenterol 45:918–927

    Article  CAS  PubMed  Google Scholar 

  28. Michalakis K, Williams CJ, Mitsiades N, Blakeman J, Balafouta-Tselenis S, Giannopoulos A, Mantzoros CS (2007) Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomarkers Prev 16:308–313

    Article  CAS  PubMed  Google Scholar 

  29. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, Chen HY, Hou MF, Yuan SS (2006) Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237:109–114

    Article  CAS  PubMed  Google Scholar 

  30. Petridou E, Mantzoros C, Dessypris N, Koukoulomatis P, Addy C, Voulgaris Z, Chrousos G, Trichopoulos D (2003) Plasma adiponectin concentrations in relation to endometrial cancer: a case–control study in Greece. J Clin Endocrinol Metab 88:993–997

    Article  CAS  PubMed  Google Scholar 

  31. Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, Kim SE, Lee GY, Lee JW, Jung SA, Chung HY, Jeong S, Kim JB (2010) Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol 24:1441–1452

    Article  CAS  PubMed  Google Scholar 

  32. Kelesidis I, Kelesidis T, Mantzoros CS (2006) Adiponectin and cancer: a systematic review. Br J Cancer 94:1221–1225

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Tsukada T, Fushida S, Harada S, Terai S, Yagi Y, Kinoshita J, Oyama K, Tajima H, Fujita H, Ninomiya I, Fujimura T, Ohta T (2011) Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer. J Exp Clin Cancer Res 30:107

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Abdul-Ghafar J, Oh SS, Park SM, Wairagu P, Lee SN, Jeong Y, Eom M, Yong SJ, Jung SH (2013) Expression of adiponectin receptor 1 is indicative of favorable prognosis in non-small cell lung carcinoma. Tohoku J Exp Med 229:153–162

    Article  CAS  PubMed  Google Scholar 

  35. Yamamoto N, Oshima T, Yoshihara K, Sato T, Yamada R, Fujii S, Nagano Y, Shiozawa M, Akaike M, Wada N, Rino Y, Kunisaki C, Masuda M, Tanaka K, Imada T (2009) Reduced expression of the AdipoR1 gene is correlated with venous invasion in colorectal cancer. Mol Med Rep 2:555–559

    Article  CAS  PubMed  Google Scholar 

  36. Byeon JS, Jeong JY, Kim MJ, Lee SM, Nam WH, Myung SJ, Kim JG, Yang SK, Kim JH, Suh DJ (2010) Adiponectin and adiponectin receptor in relation to colorectal cancer progression. Int J Cancer 127:2758–2767

    Article  CAS  PubMed  Google Scholar 

  37. Ishikawa M, Kitayama J, Yamauchi T, Kadowaki T, Maki T, Miyato H, Yamashita H, Nagawa H (2007) Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci 98:1120–1127

    Article  CAS  PubMed  Google Scholar 

  38. Man K, Ng KT, Xu A, Cheng Q, Lo CM, Xiao JW, Sun BS, Lim ZX, Cheung JS, Wu EX, Sun CK, Poon RT, Fan ST (2010) Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling. Clin Cancer Res 16:967–977

    Article  CAS  PubMed  Google Scholar 

  39. Barresi V, Grosso M, Giuffre G, Tuccari G, Barresi G (2009) The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. J Clin Pathol 62:705–709

    Article  CAS  PubMed  Google Scholar 

  40. Chiu YC, Shieh DC, Tong KM, Chen CP, Huang KC, Chen PC, Fong YC, Hsu HC, Tang CH (2009) Involvement of AdipoR receptor in adiponectin-induced motility and alpha2beta1 integrin upregulation in human chondrosarcoma cells. Carcinogenesis 30:1651–1659

    Article  CAS  PubMed  Google Scholar 

  41. Tang CH, Lu ME (2009) Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways. Prostate 69:1781–1789

    Article  CAS  PubMed  Google Scholar 

  42. Pfeiler G, Treeck O, Wenzel G, Goerse R, Hartmann A, Schmitz G, Ortmann O (2009) Influence of insulin resistance on adiponectin receptor expression in breast cancer. Maturitas 63:253–256

    Article  CAS  PubMed  Google Scholar 

  43. Howard JM, Beddy P, Ennis D, Keogan M, Pidgeon GP, Reynolds JV (2010) Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. Br J Surg 97:1020–1027

    Article  CAS  PubMed  Google Scholar 

  44. Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ, Xu A (2006) Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res 66:11462–11470

    Article  CAS  PubMed  Google Scholar 

  45. Grossmann ME, Nkhata KJ, Mizuno NK, Ray A, Cleary MP (2008) Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 98:370–379

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Seoul National University Bundang Hospital, 173-82 Gumiro, Bundang-gu, Seongnam, Gyeonggi, 463-707, South Korea

    Eun Shin

  2. Department of Surgery, College of Medicine, Korea University, 126-1 Anam-dong 5 ga, Seongbuk-gu, Seoul, 163-705, South Korea

    Young-Dong Yu & Dong-Sik Kim

  3. Department of Pathology, College of Medicine, Korea University, 126-1 Anam-dong 5 ga, Seongbuk-gu, Seoul, 163-705, South Korea

    Nam Hee Won

Authors
  1. Eun Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Young-Dong Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dong-Sik Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nam Hee Won
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nam Hee Won.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shin, E., Yu, YD., Kim, DS. et al. Adiponectin Receptor Expression Predicts Favorable Prognosis in Cases of Hepatocellular Carcinoma. Pathol. Oncol. Res. 20, 667–675 (2014). https://doi.org/10.1007/s12253-014-9747-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-014-9747-0

Keywords

Search

Navigation